Jacob Asset Management of New York’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$337K Buy
2023
Q2
$321K Sell
2023
Q1
$493K Buy
2022
Q4
$668K Buy
2022
Q3
$1.01M Buy
2022
Q2
$505K Buy
2022
Q1
$785K Buy
2021
Q4
$551K Sell
2021
Q3
$675K Buy
2021
Q2
$652K Buy
2021
Q1
$357K Hold
2020
Q4
$466K Buy